Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: A meta-analysis

Programmed cell death-ligand 1 (PD-L1) may be a useful molecule for targeted immunotherapy. Therefore, this meta-analysis aimed to investigate PD-L1 expression in breast cancer and its associations with clinicopathological factors and outcomes, which may help determine whether PD-L1 expression is a useful prognostic marker. | Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer A meta-analysis

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
42    1    0    24-10-2020
52    1    0    24-10-2020